Drug Safety Newsletter 43rd Edition
12 August 2011
Topics covered in this edition of the newsletter include:
• Pioglitazone – New contraindications and warnings following European review of bladder cancer risk
• Dexrazoxane (Cardioxane) – Restrictions for use
• Dronedarone (Multaq) – Update on benefit-risk review
• View the Drug Safety Newsletter online or via email
• Gardasil – Overview of National Monitoring Experience
• Direct Healthcare Professional Communications published on the IMB website since the last Drug Safety Newsletter
Drug Safety Newsletter 43rd Edition